Multitarget stool DNA test (MSDT)- and next-generation MSDT (N-G MSDT)-based screening have higher costs per detected ...

Investing in patient navigation and clinician incentives ensures colorectal cancer screening completion, improves early detection, reduces disparities, achieves cost savings, and advances population ...

John Johnson was diagnosed with stage 2 colorectal cancer in 2023. Two years later, he's cancer free and returning to running ...

The launch of a new nationwide screening programme for bowel cancer on Thursday offers free testing to thousands of people ...

The Affordable Care Act, aka Obamacare, has been anything but affordable. Despite all the talk about "bending the cost curve, ...

A new paper suggests that exposure to a common toxin in the stomach in early childhood may contribute to premature onset of ...

The reductions in NIH funding and staff are happening at a time when colorectal cancer cases have been rising among younger ...

Digestive Disease Week, the annual meeting sponsored by the American Association for the Study of Liver Diseases, American ...

Analysis conducted by Microba of 4,616 MetaXplore™ GI Plus patients test results from Australia revealed that 71.4% (3,295) of reports identified actionable results.